Imbalance of a KLF4-miR-7 auto-regulatory feedback loop promotes prostate cancer cell growth by impairing microRNA processing.

The microRNA-transcription factor auto-regulatory feedback loop is a pivotal mechanism for homeostatic regulation of gene expression, and dysregulation of the feedback loop is tightly associated with tumorigenesis and progression. However, the mechanism underlying such dysregulation is still not well-understood. Here we reported that Krüppel-like factor 4 (KLF4), a stemness-associated transcription factor, promotes the transcription of miR-7 to repress its own translation so that a KLF4-miR-7 auto-regulatory feedback loop is established for mutual regulation of their expression. Interestingly, this feedback loop is unbalanced in prostate cancer (PCa) cell lines and patient samples due to an impaired miR-7-processing, leading to decreased mature miR-7 production and attenuated inhibition of KLF4 translation. Mechanistically, enhanced oncogenic Yes associated protein (YAP) nuclear translocation mediates sequestration of p72, a co-factor of the Drosha/DGCR8 complex for pri-miR-7s processing, leading to attenuation of microprocessors' efficiency. Knockdown of YAP or transfection with a mature miR-7 mimic can significantly recover miR-7 expression to restore this feedback loop, and in turn to inhibit cancer cell growth by repressing KLF4 expression in vitro. Thus, our findings indicate that targeting the KLF4-miR-7 feedback loop might be a potential strategy for PCa therapy.

[1]  M. Ittmann,et al.  Differential expression of stem cell markers and ABCG2 in recurrent prostate cancer , 2014, The Prostate.

[2]  Q. Wei,et al.  A functional variant at miRNA-122 binding site in IL-1α 3' UTR predicts risk and HPV-positive tumours of oropharyngeal cancer. , 2015, European journal of cancer.

[3]  R. Shiekhattar,et al.  The Microprocessor complex mediates the genesis of microRNAs , 2004, Nature.

[4]  Juanjuan Zhao,et al.  MicroRNA-7: a promising new target in cancer therapy , 2015, Cancer Cell International.

[5]  R. Place,et al.  Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration. , 2010, Cancer research.

[6]  Chen-Chung Lin,et al.  A KLF4–miRNA-206 Autoregulatory Feedback Loop Can Promote or Inhibit Protein Translation Depending upon Cell Context , 2011, Molecular and Cellular Biology.

[7]  Min Gyu Lee,et al.  A feedback loop comprising PRMT7 and miR-24-2 interplays with Oct4, Nanog, Klf4 and c-Myc to regulate stemness , 2016, Nucleic acids research.

[8]  A. Krainer,et al.  A splicing-independent function of SF2/ASF in microRNA processing. , 2010, Molecular cell.

[9]  Paul C. Boutros,et al.  Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER , 2014, Nature Communications.

[10]  Wei-Qiang Gao,et al.  Regulation and Methylation of Tumor Suppressor MiR-124 by Androgen Receptor in Prostate Cancer Cells , 2015, PloS one.

[11]  Z. Ji,et al.  MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway , 2015, Oncotarget.

[12]  D. Peeper,et al.  KLF4, p21 and context-dependent opposing forces in cancer , 2006, Nature Reviews Cancer.

[13]  T. Tomasi,et al.  The modulation of Dicer regulates tumor immunogenicity in melanoma , 2016, Oncotarget.

[14]  An-Yuan Guo,et al.  MicroRNA and transcription factor co-regulatory network analysis reveals miR-19 inhibits CYLD in T-cell acute lymphoblastic leukemia , 2012, Nucleic acids research.

[15]  W. Foulkes,et al.  DICER1: mutations, microRNAs and mechanisms , 2014, Nature Reviews Cancer.

[16]  C. Thomssen,et al.  The oncogenic triangle of HMGA2, LIN28B and IGF2BP1 antagonizes tumor-suppressive actions of the let-7 family , 2016, Nucleic acids research.

[17]  Qin Chen,et al.  SUMOylation at K707 of DGCR8 controls direct function of primary microRNA , 2015, Nucleic acids research.

[18]  Qi Li,et al.  Suppression of epithelial-mesenchymal transition in hepatocellular carcinoma cells by Krüppel-like factor 4 , 2016, Oncotarget.

[19]  G. Calin,et al.  Hypoxia Mediated Downregulation of miRNA Biogenesis Promotes Tumor Progression , 2014, Nature Communications.

[20]  Toru Suzuki,et al.  miR-200c-SUMOylated KLF4 feedback loop acts as a switch in transcriptional programs that control VSMC proliferation. , 2015, Journal of molecular and cellular cardiology.

[21]  Dong Hu,et al.  Critical and Reciprocal Regulation of KLF4 and SLUG in Transforming Growth Factor β-Initiated Prostate Cancer Epithelial-Mesenchymal Transition , 2011, Molecular and Cellular Biology.

[22]  F. Camargo,et al.  Hippo Signaling Regulates Microprocessor and Links Cell-Density-Dependent miRNA Biogenesis to Cancer , 2014, Cell.

[23]  Y. Mo,et al.  miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4. , 2013, Cancer research.

[24]  Ling Tian,et al.  MicroRNA‐7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3‐kinase/Akt pathway in hepatocellular carcinoma , 2012, Hepatology.

[25]  Xin-Yu Na,et al.  Long non-coding RNA UCA1 contributes to the progression of prostate cancer and regulates proliferation through KLF4-KRT6/13 signaling pathway. , 2015, International journal of clinical and experimental medicine.

[26]  Jing Wang,et al.  MiR‐7, Inhibited Indirectly by LincRNA HOTAIR, Directly Inhibits SETDB1 and Reverses the EMT of Breast Cancer Stem Cells by Downregulating the STAT3 Pathway , 2014, Stem cells.

[27]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[28]  Yi Ma,et al.  Consent for Use of Clinical Leftover Biosample: A Survey among Chinese Patients and the General Public , 2012, PloS one.

[29]  C. Norbury,et al.  The Long and Short of MicroRNA , 2013, Cell.

[30]  Yang Liu,et al.  An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3' untranslated region confers risk for hepatocellular carcinoma. , 2009, Carcinogenesis.

[31]  Julia Schüler,et al.  The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs , 2009, Nature Cell Biology.

[32]  K. Ohshiro,et al.  MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions. , 2008, Cancer research.